Skip to main content
. 2025 Apr 15;13:1521908. doi: 10.3389/fped.2025.1521908

Table 4.

Maternal and neonatal characteristics of infants with EOS according to gestational age.

Characteristics <32 weeks
(n = 17)
32–36 weeks
(n = 20)
≥37 weeks
(n = 94)
Total
(N = 131)
Birth weight, g, mean (SD) 1,333 (302) 2,168 (590) 3,267 (470) 2,857 (845)
Female, n (%) 6 (35.3) 9 (47.4) 43 (45.3) 58 (44.3)
Apgar ≥7 at 1 min, n (%) 14 (82.4) 19 (100.0) 91 (96.8) 124 (95.4)
Mother's age, years, mean (SD) 32.4 (5.0) 30.6 (4.8) 29.9 (3.7) 30.3 (4.1)
Method of delivery, n (%)
 Vaginal 8 (47.1) 5 (26.3) 76 (80.0) 89 (67.9)
 Caesarean section 9 (52.9) 14 (73.7) 19 (20.0) 42 (32.1)
PROM, n (%) 10 (58.8) 9 (47.4) 32 (33.7) 51 (38.9)
Clinical chorioamnionitis, n (%) 10 (58.8) 2 (10.5) 9 (9.5) 21 (16.0)
Antenatal GBS screening, n (%) 15 (88.2) 13 (68.4) 73 (77.7) 101 (77.7)
 Positive 1 (6.7) 3 (23.1) 9 (12.3) 13 (12.9)
 Negative 14 (93.3) 10 (76.9) 64 (87.7) 88 (87.1)
Intrapartum antibiotic use, n (%) 13 (76.5) 15 (78.9) 31 (33.0) 59 (45.4)
Comorbidity, n (%)
 Bacterial meningitis 0 (0.0) 3 (15.8) 3 (3.2) 6 (4.6)
 Intracranial hemorrhage 10 (58.8) 3 (15.8) 5 (5.3) 18 (13.7)
 Septic shock 4 (23.5) 2 (10.5) 9 (9.5) 15 (11.5)
Invasive mechanical ventilation, n (%) 12 (70.6) 3 (15.8) 12 (12.6) 27 (20.6)
PN use, n (%) 17 (100.0) 17 (89.5) 41 (43.2) 75 (57.3)
Length of stay, days, median (IQR) 42 (22.5–69.5) 16 (14–21) 12 (10–14) 12 (11–17)
Transfer to another hospital, n (%) 1 (5.9) 1 (5.3) 4 (4.2) 6 (4.6)
Death, n (%) 4 (23.5) 1 (5.3) 0 (0.0) 5 (3.8)

PROM, premature rupture of membranes; GBS, group B Streptococcus; PN, parenteral nutrition.

Data was not available in 1 infant (Apgar); 1 infant (GBS screening); 1 infant (Intrapartum antibiotic use).